With the use of CGM guidance to adjust the insulin regimen, the HbA1c of patients with diabetes and HD decreased from 8.4±1.0% to 7.6±1.0%, and the average glucose value decreased from 9.9±1.9 mmol/L to 8.9±2.1 mmol/L. This evidence concerns the gene INS and diabetes mellitus.